Written Question·Department of Health and Social Care·UIN 10377

Vitiligo: Ruxolitinib

Tabled: 21 October 2024

Answered: 29 October 2024

Question

Luke Taylor

To ask the Secretary of State for Health and Social Care, whether he plans to review the National Institute for Health and Care Excellence's decision not to recommend Ruxolitinib for use within NHS England for the treatment of vitiligo.

Answer

Karin Smyth

The National Institute for Health and Care Excellence (NICE) is currently developing guidance for the National Health Service on whether ruxolitinib should be routinely funded by the NHS, based on an assessment of its costs and benefits.The NICE was unfor...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 10377) →